Day One Biopharmaceuticals (DAWN) Leases: 2022-2025
Historic Leases for Day One Biopharmaceuticals (DAWN) over the last 4 years, with Sep 2025 value amounting to $2.5 million.
- Day One Biopharmaceuticals' Leases fell 4.82% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year decrease of 4.82%. This contributed to the annual value of $2.4 million for FY2024, which is 588.07% up from last year.
- As of Q3 2025, Day One Biopharmaceuticals' Leases stood at $2.5 million, which was down 1.96% from $2.5 million recorded in Q2 2025.
- Day One Biopharmaceuticals' 5-year Leases high stood at $2.6 million for Q1 2025, and its period low was $164,000 during Q2 2024.
- Moreover, its 3-year median value for Leases was $616,000 (2023), whereas its average is $1.4 million.
- Per our database at Business Quant, Day One Biopharmaceuticals' Leases slumped by 69.06% in 2024 and then skyrocketed by 1,423.78% in 2025.
- Over the past 4 years, Day One Biopharmaceuticals' Leases (Quarterly) stood at $699,000 in 2022, then slumped by 49.64% to $352,000 in 2023, then spiked by 588.07% to $2.4 million in 2024, then declined by 4.82% to $2.5 million in 2025.
- Its last three reported values are $2.5 million in Q3 2025, $2.5 million for Q2 2025, and $2.6 million during Q1 2025.